News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
genesis-biomed-socio-asebio-biotech
NLP will allow important advances in all fields, and especially in the field of health
Access to innovation · Digitalization
Natural language processing (NLP) systems are a key branch of artificial intelligence that…
Partners - GENESIS Biomed
Oncostellae Team
The Galician biopharmaceutical Oncostellae opens an office at the Barcelona Science Park
Healthcare · Innovative drugs · Advanced therapies
The company specialises in the development of molecules for oncological and gastrointestinal…
Partners - Parc Científic de Barcelona
Parque Científico de Barcelona
Barcelona Science Park companies break record after raising €142M in 2022
Healthcare · Access to innovation · Financing
2022 has been a historic year in economic and innovation indicators for the ecosystem of…
Partners - Parc Científic de Barcelona
oryzon-noticia-socio-asebio-biotech
Oryzon announces completed patient recruitment in the PORTICO Phase IIb trial of vafidemstat in Borderline Personality Disorder
Corporate
Multiple primary endpoints include reduction in agitation and aggression and overall disease…
Partners - Oryzon Genomics
Oryzon-Asebio-Biotecnologia
ORYZON reports financial results and corporate updates for half-year ending June 30, 2023
Corporate
Partners - Oryzon Genomics
Orikine
Orikine Bio closes €5.5m Series Seed Financing with Sabadell Asabys and AdBio
Financing · Corporate
New synthetic biology spin-off from the Centre for Genomic Regulation (CRG) in Barcelona developing…
Partners - Asabys Partners
Biorreactores empleados en VIVEbiotech
VIVEbiotech participates in the European MAGIC project
Healthcare · Personalized medicine · Advanced therapies · Gene editing · International · EU projects · Financing
VIVEbiotech is a CDMO GMP that develops and manufactures lentiviral vectors from early stage to…
Partners - VIVEbiotech
Primera conferencia Cátedra UAM PEACHES
The use of cell secretomes opens a new era of advanced therapies
Drug discovery · Innovative drugs · Personalized medicine · Advanced therapies
The UAM-PEACHES Chair on cell therapies has taken place at the Autonomous University of Madrid (UAM…
Partners - PEACHES BIOTECH S.L.
Paciente_ensayo
Positive aggregate safety data from vafidemstat’s ongoing Phase IIb PORTICO trial in Borderline Personality Disorder
Access to innovation
Recommendation from the independent Data Monitoring Committee (DMC) to continue the PORTICO trial…
Partners - Oryzon Genomics